来源：丁香园Insight数据库2 月 13 日，CDE 官网显示，阿斯利康Baxdrostat 片上市申请获受理。根据临床试验进展，Insight 数据库推测适应症为高血压。来源：CDE 官网Baxdrostat 是一种全球首创、高选择性的醛固酮合成酶抑制剂（ASI），可抑制醛固酮合酶。该酶由 CYP11B2 基因编码，负责肾上腺中醛固酮的合成。临床研究表明，Baxdrostat 可在较大剂量...
Source Link来源：丁香园Insight数据库2 月 13 日，CDE 官网显示，阿斯利康Baxdrostat 片上市申请获受理。根据临床试验进展，Insight 数据库推测适应症为高血压。来源：CDE 官网Baxdrostat 是一种全球首创、高选择性的醛固酮合成酶抑制剂（ASI），可抑制醛固酮合酶。该酶由 CYP11B2 基因编码，负责肾上腺中醛固酮的合成。临床研究表明，Baxdrostat 可在较大剂量...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.